JP2012533334A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012533334A5 JP2012533334A5 JP2012520148A JP2012520148A JP2012533334A5 JP 2012533334 A5 JP2012533334 A5 JP 2012533334A5 JP 2012520148 A JP2012520148 A JP 2012520148A JP 2012520148 A JP2012520148 A JP 2012520148A JP 2012533334 A5 JP2012533334 A5 JP 2012533334A5
- Authority
- JP
- Japan
- Prior art keywords
- matrix composition
- orthopedic
- active agent
- pharmaceutically active
- biodegradable polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 28
- 239000011159 matrix material Substances 0.000 claims 25
- 230000000399 orthopedic effect Effects 0.000 claims 12
- 239000013543 active substance Substances 0.000 claims 11
- 229920002988 biodegradable polymer Polymers 0.000 claims 10
- 239000004621 biodegradable polymer Substances 0.000 claims 10
- 150000002632 lipids Chemical class 0.000 claims 7
- 102000008186 Collagen Human genes 0.000 claims 5
- 108010035532 Collagen Proteins 0.000 claims 5
- 239000002202 Polyethylene glycol Substances 0.000 claims 5
- 229920001436 collagen Polymers 0.000 claims 5
- 229920001223 polyethylene glycol Polymers 0.000 claims 5
- 210000000988 bone and bone Anatomy 0.000 claims 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims 4
- 239000002245 particle Substances 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 150000003904 phospholipids Chemical class 0.000 claims 4
- 239000000758 substrate Substances 0.000 claims 4
- 229940078581 Bone resorption inhibitor Drugs 0.000 claims 3
- 229930182558 Sterol Natural products 0.000 claims 3
- 239000011248 coating agent Substances 0.000 claims 3
- 238000000576 coating method Methods 0.000 claims 3
- 239000000945 filler Substances 0.000 claims 3
- 239000007943 implant Substances 0.000 claims 3
- 239000003960 organic solvent Substances 0.000 claims 3
- 230000002188 osteogenic effect Effects 0.000 claims 3
- 150000003432 sterols Chemical class 0.000 claims 3
- 235000003702 sterols Nutrition 0.000 claims 3
- 238000013268 sustained release Methods 0.000 claims 3
- 239000012730 sustained-release form Substances 0.000 claims 3
- ZSZRUEAFVQITHH-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)ethyl 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CC(=C)C(=O)OCCOP([O-])(=O)OCC[N+](C)(C)C ZSZRUEAFVQITHH-UHFFFAOYSA-N 0.000 claims 2
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 claims 2
- 239000004793 Polystyrene Substances 0.000 claims 2
- 239000003242 anti bacterial agent Substances 0.000 claims 2
- 229940088710 antibiotic agent Drugs 0.000 claims 2
- 229940121375 antifungal agent Drugs 0.000 claims 2
- 229920001400 block copolymer Polymers 0.000 claims 2
- 239000002617 bone density conservation agent Substances 0.000 claims 2
- 235000012000 cholesterol Nutrition 0.000 claims 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 2
- 239000012528 membrane Substances 0.000 claims 2
- 229910052751 metal Inorganic materials 0.000 claims 2
- 239000002184 metal Substances 0.000 claims 2
- 230000011164 ossification Effects 0.000 claims 2
- 201000001245 periodontitis Diseases 0.000 claims 2
- 229920000642 polymer Polymers 0.000 claims 2
- -1 polyoxymethylene Polymers 0.000 claims 2
- 229920002223 polystyrene Polymers 0.000 claims 2
- 239000003356 suture material Substances 0.000 claims 2
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims 1
- WDQMWEYDKDCEHT-UHFFFAOYSA-N 2-ethylhexyl 2-methylprop-2-enoate Chemical compound CCCCC(CC)COC(=O)C(C)=C WDQMWEYDKDCEHT-UHFFFAOYSA-N 0.000 claims 1
- WLZPCFOGJNCCRJ-UHFFFAOYSA-M 4-ethenyl-1-ethylpyridin-1-ium;bromide Chemical compound [Br-].CC[N+]1=CC=C(C=C)C=C1 WLZPCFOGJNCCRJ-UHFFFAOYSA-M 0.000 claims 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims 1
- 229910000684 Cobalt-chrome Inorganic materials 0.000 claims 1
- 102000009123 Fibrin Human genes 0.000 claims 1
- 108010073385 Fibrin Proteins 0.000 claims 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims 1
- 108010010803 Gelatin Proteins 0.000 claims 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims 1
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 claims 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims 1
- 229930040373 Paraformaldehyde Natural products 0.000 claims 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 claims 1
- 239000004952 Polyamide Substances 0.000 claims 1
- 108010039918 Polylysine Proteins 0.000 claims 1
- 239000004743 Polypropylene Substances 0.000 claims 1
- 229910001069 Ti alloy Inorganic materials 0.000 claims 1
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 claims 1
- WAIPAZQMEIHHTJ-UHFFFAOYSA-N [Cr].[Co] Chemical compound [Cr].[Co] WAIPAZQMEIHHTJ-UHFFFAOYSA-N 0.000 claims 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 229920000249 biocompatible polymer Polymers 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 239000004568 cement Substances 0.000 claims 1
- 239000000919 ceramic Substances 0.000 claims 1
- 239000010952 cobalt-chrome Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 229920001577 copolymer Polymers 0.000 claims 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 1
- 239000003479 dental cement Substances 0.000 claims 1
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 claims 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 claims 1
- 238000001704 evaporation Methods 0.000 claims 1
- 150000004665 fatty acids Chemical group 0.000 claims 1
- 229950003499 fibrin Drugs 0.000 claims 1
- 235000021588 free fatty acids Nutrition 0.000 claims 1
- 229920000159 gelatin Polymers 0.000 claims 1
- 239000008273 gelatin Substances 0.000 claims 1
- 235000019322 gelatine Nutrition 0.000 claims 1
- 235000011852 gelatine desserts Nutrition 0.000 claims 1
- 229960002897 heparin Drugs 0.000 claims 1
- 229920000669 heparin Polymers 0.000 claims 1
- 239000008240 homogeneous mixture Substances 0.000 claims 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims 1
- 150000003905 phosphatidylinositols Chemical class 0.000 claims 1
- 229920002647 polyamide Polymers 0.000 claims 1
- 229920000656 polylysine Polymers 0.000 claims 1
- 229920006324 polyoxymethylene Polymers 0.000 claims 1
- 229920001155 polypropylene Polymers 0.000 claims 1
- 229920001296 polysiloxane Polymers 0.000 claims 1
- 229920002635 polyurethane Polymers 0.000 claims 1
- 239000004814 polyurethane Substances 0.000 claims 1
- 229920000915 polyvinyl chloride Polymers 0.000 claims 1
- 239000004800 polyvinyl chloride Substances 0.000 claims 1
- 150000003408 sphingolipids Chemical class 0.000 claims 1
- 239000010935 stainless steel Substances 0.000 claims 1
- 229910001220 stainless steel Inorganic materials 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
- 229910052715 tantalum Inorganic materials 0.000 claims 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 claims 1
- 230000008685 targeting Effects 0.000 claims 1
- 229960001295 tocopherol Drugs 0.000 claims 1
- 229930003799 tocopherol Natural products 0.000 claims 1
- 235000010384 tocopherol Nutrition 0.000 claims 1
- 239000011732 tocopherol Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22528909P | 2009-07-14 | 2009-07-14 | |
| US61/225,289 | 2009-07-14 | ||
| PCT/IL2010/000563 WO2011007353A1 (en) | 2009-07-14 | 2010-07-14 | Sustained-release drug carrier composition |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012533334A JP2012533334A (ja) | 2012-12-27 |
| JP2012533334A5 true JP2012533334A5 (enExample) | 2013-08-29 |
| JP5738856B2 JP5738856B2 (ja) | 2015-06-24 |
Family
ID=43448999
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012520148A Active JP5738856B2 (ja) | 2009-07-14 | 2010-07-14 | 徐放性薬物担体組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US8992979B2 (enExample) |
| EP (1) | EP2453877B1 (enExample) |
| JP (1) | JP5738856B2 (enExample) |
| CN (2) | CN102470105B (enExample) |
| AU (1) | AU2010272167B2 (enExample) |
| CA (1) | CA2767973C (enExample) |
| ES (1) | ES2732149T3 (enExample) |
| IN (1) | IN2012DN00570A (enExample) |
| WO (1) | WO2011007353A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5681626B2 (ja) | 2008-07-14 | 2015-03-11 | ポリーペイド リミテッドＰｏｌｙｐｉｄ Ｌｔｄ． | 徐放性薬剤キャリア組成物 |
| AU2011208374B2 (en) | 2010-01-19 | 2016-09-08 | Polypid Ltd. | Sustained-release nucleic acid matrix compositions |
| EP2736492A4 (en) * | 2011-07-27 | 2015-06-17 | Polypid Ltd | MATRIX COMPOSITIONS FOR THE CONTROLLED RELEASE OF PEPTIDES AND POLYPEPTIDE MOLECULES |
| JP5900909B2 (ja) * | 2012-03-27 | 2016-04-06 | 国立大学法人名古屋大学 | ポリヒドロキシアルカノエートを含む材料から作製された３次元構造体、及び骨充填材の調製用キット |
| NZ704066A (en) * | 2012-08-02 | 2017-06-30 | Polypid Ltd | Compositions and methods for the treatment of bone voids and open fractures |
| MX2015006002A (es) * | 2012-11-14 | 2016-02-05 | Orthopaedic Innovation Ct Inc | Articulos antimicrobianos producidos por fabricacion aditiva. |
| US9775853B2 (en) | 2013-03-15 | 2017-10-03 | Biomet Manufacturing, Llc. | Hemostatic compositions and methods |
| TW201618783A (zh) | 2014-08-07 | 2016-06-01 | 艾森塔製藥公司 | 以布魯頓(Bruton)氏酪胺酸激酶(BTK)佔據和BTK再合成速率為基礎之治療癌症、免疫和自體免疫疾病及發炎性疾病之方法 |
| JP6526400B2 (ja) * | 2014-09-11 | 2019-06-05 | サンスター株式会社 | 口腔用組成物 |
| SG10202012452UA (en) * | 2014-10-02 | 2021-01-28 | Polypid Ltd | Compositions and methods for the treatment and prophylaxis of surgical site infections |
| SG11201702700UA (en) * | 2014-10-02 | 2017-04-27 | Polypid Ltd | Methods for the treatment of peri-implantitis |
| CN108601930B (zh) * | 2016-02-08 | 2021-12-14 | 祥丰医疗私人有限公司 | 药物洗脱球囊 |
| US10792477B2 (en) | 2016-02-08 | 2020-10-06 | Orbusneich Medical Pte. Ltd. | Drug eluting balloon |
| CN106146761A (zh) * | 2016-06-03 | 2016-11-23 | 西北大学 | 一种两亲性多功能聚合物及其制备的纳米胶束和应用 |
| JP7102423B2 (ja) * | 2017-02-16 | 2022-07-19 | イェダ リサーチ アンド ディベロップメント カンパニー リミテッド | リポソームの薬物送達ビヒクル |
| WO2019222856A1 (en) | 2018-05-24 | 2019-11-28 | Nureva Inc. | Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones |
| AU2019275406B2 (en) | 2018-05-24 | 2024-11-14 | Celanese Eva Performance Polymers Llc | Implantable device for sustained release of a macromolecular drug compound |
| WO2019226519A1 (en) | 2018-05-24 | 2019-11-28 | Celanese EVA Performance Polymers Corporation | Implantable device for sustained release of a macromolecular drug compound |
| JP7662204B2 (ja) | 2019-07-03 | 2025-04-15 | アトッサ・セラピューティクス・インコーポレイテッド | エンドキシフェンの徐放性組成物 |
| CA3166413C (en) | 2021-02-01 | 2024-04-09 | Alon Green | Systems and methods of calibrating a range measurement system |
| CN113081482B (zh) * | 2021-04-23 | 2024-02-27 | 柏为（武汉）医疗科技股份有限公司 | 一种中耳防粘连膜及其制备方法 |
| WO2022231930A1 (en) | 2021-04-26 | 2022-11-03 | Celanese Eva Performance Polymers Llc | Implantable device for sustained release of a macromolecular drug compound |
| CN113702647B (zh) * | 2021-08-31 | 2024-03-15 | 普十生物科技(北京)有限公司 | 人生长分化因子15即时检测试剂盒、其制备方法及其应用 |
Family Cites Families (74)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4522803A (en) | 1983-02-04 | 1985-06-11 | The Liposome Company, Inc. | Stable plurilamellar vesicles, their preparation and use |
| US4882167A (en) | 1983-05-31 | 1989-11-21 | Jang Choong Gook | Dry direct compression compositions for controlled release dosage forms |
| US4578384A (en) | 1984-02-15 | 1986-03-25 | The United States Of America As Represented By The Secretary Of The Army | Polylactic-polyglycolic acids combined with an acidic phospholipid-lysozyme complex for healing osseous tissue |
| JPS6163613A (ja) | 1984-09-04 | 1986-04-01 | Mitsui Toatsu Chem Inc | 顆粒状に調整された徐放性製剤 |
| US5043166A (en) | 1987-01-09 | 1991-08-27 | Hadasit Medical Research, Inc. | Liposome/anthraquinone drug composition and method |
| IL91664A (en) | 1988-09-28 | 1993-05-13 | Yissum Res Dev Co | Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release |
| CA2068216C (en) | 1989-11-13 | 1999-04-13 | Abraham J. Domb | Lipospheres for controlled delivery of substances |
| US6120805A (en) | 1990-04-06 | 2000-09-19 | Rhone-Poulenc Rorer Sa | Microspheres, process for their preparation and their use |
| US5922340A (en) | 1992-09-10 | 1999-07-13 | Children's Medical Center Corporation | High load formulations and methods for providing prolonged local anesthesia |
| US6180134B1 (en) | 1993-03-23 | 2001-01-30 | Sequus Pharmaceuticals, Inc. | Enhanced ciruclation effector composition and method |
| WO1995024929A2 (en) | 1994-03-15 | 1995-09-21 | Brown University Research Foundation | Polymeric gene delivery system |
| US6156337A (en) | 1994-07-08 | 2000-12-05 | Opperbas Holding B.V. | Method for high loading of vesicles with biopolymeric substances |
| US6333021B1 (en) | 1994-11-22 | 2001-12-25 | Bracco Research S.A. | Microcapsules, method of making and their use |
| US6040295A (en) | 1995-01-13 | 2000-03-21 | Genemedicine, Inc. | Formulated nucleic acid compositions and methods of administering the same for gene therapy |
| US5919480A (en) | 1996-06-24 | 1999-07-06 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Liposomal influenza vaccine composition and method |
| US5837221A (en) | 1996-07-29 | 1998-11-17 | Acusphere, Inc. | Polymer-lipid microencapsulated gases for use as imaging agents |
| WO1998007412A1 (en) | 1996-08-21 | 1998-02-26 | Alkermes Controlled Therapeutics, Inc. | Controlled release microparticles with a hydrophobic material |
| DE69718519T2 (de) | 1996-09-11 | 2003-11-06 | Imarx Pharmaceutical Corp., Tucson | Verbesserte verfahren zur diagnostischen bilderzeugung unter verwendung eines kontrastmittels und eines vasodilators |
| US6048551A (en) | 1997-03-27 | 2000-04-11 | Hilfinger; John M. | Microsphere encapsulation of gene transfer vectors |
| BR9815499A (pt) | 1997-07-02 | 2001-01-02 | Euro Celtique Sa | Anestesia prolongada nas juntas e nos espacos corporais. |
| US6287587B2 (en) | 1997-07-15 | 2001-09-11 | Takeda Chemical Industries, Ltd. | Process for producing sustained-release preparation by in-water drying |
| US6787132B1 (en) | 1997-12-04 | 2004-09-07 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Combined chemo-immunotherapy with liposomal drugs and cytokines |
| CA2329768C (en) | 1998-04-27 | 2008-06-10 | Opperbas Holding B.V. | Pharmaceutical composition comprising factor viii and neutral liposomes |
| US6423345B2 (en) | 1998-04-30 | 2002-07-23 | Acusphere, Inc. | Matrices formed of polymer and hydrophobic compounds for use in drug delivery |
| WO2000003660A1 (en) | 1998-07-17 | 2000-01-27 | Skyepharma, Inc. | Biodegradable compositions for the controlled release of encapsulated substances |
| IL140892A0 (en) | 1998-08-12 | 2002-02-10 | Yissum Res Dev Co | Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient |
| US6153217A (en) | 1999-01-22 | 2000-11-28 | Biodelivery Sciences, Inc. | Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents |
| US6083482A (en) | 1999-05-11 | 2000-07-04 | Icn Pharmaceuticals, Inc. | Conformationally locked nucleosides and oligonucleotides |
| WO2000078357A2 (en) | 1999-06-18 | 2000-12-28 | The Collaborative Group, Ltd. | Hyaluronic acid film and matrix for sustained gene transfer |
| DE10001172A1 (de) | 2000-01-13 | 2001-07-26 | Max Planck Gesellschaft | Templatieren von Feststoffpartikeln mit Polymermultischichten |
| US6967028B2 (en) | 2000-07-31 | 2005-11-22 | Mainelab | Prolonged release microspheres for injectable administration |
| US20030161809A1 (en) * | 2000-10-02 | 2003-08-28 | Houston L. L. | Compositions and methods for the transport of biologically active agents across cellular barriers |
| FI20010540A0 (fi) | 2001-03-16 | 2001-03-16 | Yli Urpo Antti | Komposiitti pehmyt- ja kovakudosvammojen korjaamiseksi ja mainitun komposiitin käyttö |
| CA2447984A1 (en) | 2001-09-28 | 2003-04-03 | Mcneil-Ppc, Inc. | Dosage forms having an inner core and outer shell with different shapes |
| TWI226249B (en) | 2001-12-19 | 2005-01-11 | Ind Tech Res Inst | Biodegradable composite matrix for enhancing angiogenesis |
| EP1509203B1 (en) | 2002-05-15 | 2016-04-13 | California Pacific Medical Center | Delivery of nucleic acid-like compounds |
| US20040062778A1 (en) * | 2002-09-26 | 2004-04-01 | Adi Shefer | Surface dissolution and/or bulk erosion controlled release compositions and devices |
| AU2004211991B2 (en) * | 2003-02-12 | 2011-03-31 | Syncera, Inc. | Random and non-random alkylene oxide polymer alloy compositions |
| GB0305941D0 (en) | 2003-03-14 | 2003-04-23 | Camurus Ab | Composition |
| US8097273B2 (en) | 2003-04-10 | 2012-01-17 | Teijin Limited | Biodegradable film having honeycomb structure |
| US20040247624A1 (en) * | 2003-06-05 | 2004-12-09 | Unger Evan Charles | Methods of making pharmaceutical formulations for the delivery of drugs having low aqueous solubility |
| US20060188573A1 (en) * | 2003-06-10 | 2006-08-24 | Anna Imberg | Composite materials and particles |
| US20050249697A1 (en) | 2003-09-24 | 2005-11-10 | Uhrich Kathryn E | Compositions and methods for the inhibition of bone growth and resorption |
| TW200518794A (en) | 2003-11-21 | 2005-06-16 | Teijin Ltd | Substrate for tissue regeneration, composite thereof with cell and process for producing the same |
| US20050191344A1 (en) | 2004-01-15 | 2005-09-01 | Samuel Zalipsky | Liposome composition for delivery of therapeutic agents |
| US8277831B2 (en) * | 2004-02-17 | 2012-10-02 | Advanced Technologies And Regenerative Medicine, Llc. | Drug-enhanced adhesion prevention |
| US7744644B2 (en) | 2004-03-19 | 2010-06-29 | Boston Scientific Scimed, Inc. | Medical articles having regions with polyelectrolyte multilayer coatings for regulating drug release |
| DE102004025495A1 (de) * | 2004-05-21 | 2005-12-15 | Dr. Suwelack Skin & Health Care Ag | Verfahren zur Herstellung von Alginat-haltigen porösen Formkörpern |
| EP1768650B1 (en) | 2004-06-04 | 2008-07-16 | Camurus Ab | Liquid depot formulations |
| KR20070057767A (ko) * | 2004-06-15 | 2007-06-07 | 앤드류 셴 천 | 인지질 조성물 및 이의 제조 및 사용 방법 |
| CN101005828B (zh) | 2004-06-17 | 2012-01-11 | 维尔恩公司 | 用于经粘膜递送活性成分的包含粘膜粘附蛋白和所述活性物质的组合物 |
| EP1796653A2 (en) | 2004-07-26 | 2007-06-20 | Actelion Pharmaceuticals Ltd. | Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation |
| US8790672B2 (en) * | 2005-02-22 | 2014-07-29 | Nina M. Lamba-Kohli | Generation of antimicrobial surfaces using dendrimer biocides |
| JP2008539260A (ja) | 2005-04-25 | 2008-11-13 | アムジエン・インコーポレーテツド | ポロゲンを含む生分解性プチド徐放性組成物 |
| US20070141134A1 (en) | 2005-12-16 | 2007-06-21 | Kosak Matthew K | Shielded micelles for polynucleotide delivery |
| US20090318355A1 (en) | 2006-02-15 | 2009-12-24 | Chen Thomas T | Compositions and methods for promoting tissue repair and wound healing |
| CA2648099C (en) | 2006-03-31 | 2012-05-29 | The Brigham And Women's Hospital, Inc | System for targeted delivery of therapeutic agents |
| US8703167B2 (en) * | 2006-06-05 | 2014-04-22 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug |
| US8216259B2 (en) * | 2006-06-21 | 2012-07-10 | The Board Of Trustees Of The Leland Stanford Jr. University | Compositions and methods for joining non-conjoined lumens |
| CN101209243B (zh) * | 2006-12-29 | 2010-12-08 | 石药集团中奇制药技术（石家庄）有限公司 | 一种脂质体药物及其制备方法 |
| US9326979B2 (en) * | 2007-03-02 | 2016-05-03 | Teika Pharmaceutical Co., Ltd. | Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same |
| WO2008124634A1 (en) | 2007-04-04 | 2008-10-16 | Massachusetts Institute Of Technology | Polymer-encapsulated reverse micelles |
| WO2009006311A2 (en) * | 2007-06-29 | 2009-01-08 | Wisconsin Alumni Research Foundation | Structuring effect of cholesterol in peg-phospholipid micelles, drug delivery of amphotericin b, and combination antifungals |
| US20090110713A1 (en) | 2007-10-31 | 2009-04-30 | Florencia Lim | Biodegradable polymeric materials providing controlled release of hydrophobic drugs from implantable devices |
| BRPI0820302A2 (pt) | 2007-11-09 | 2015-05-19 | Univ Northeastern | Nanopartículas semelhantes a micelas de automontagem para liberação sistêmica de gene |
| WO2009110939A2 (en) | 2007-12-10 | 2009-09-11 | Massachusetts Institute Of Technology | Drug delivery system for pharmaceuticals and radiation |
| US8128983B2 (en) | 2008-04-11 | 2012-03-06 | Abbott Cardiovascular Systems Inc. | Coating comprising poly(ethylene glycol)-poly(lactide-glycolide-caprolactone) interpenetrating network |
| NZ588583A (en) | 2008-04-15 | 2012-08-31 | Protiva Biotherapeutics Inc | Novel lipid formulations for nucleic acid delivery |
| JP5681626B2 (ja) | 2008-07-14 | 2015-03-11 | ポリーペイド リミテッドＰｏｌｙｐｉｄ Ｌｔｄ． | 徐放性薬剤キャリア組成物 |
| WO2010078517A2 (en) | 2008-12-31 | 2010-07-08 | Sirnaomics, Inc. | Compositions and methods using sirna molecules and sirna cocktails for the treatment of breast cancer |
| WO2010135207A1 (en) | 2009-05-16 | 2010-11-25 | Agave Pharma, Incorporated | Compositions comprising cationic amphiphiles and colipids for delivering therapeutics molecules |
| AU2011208374B2 (en) | 2010-01-19 | 2016-09-08 | Polypid Ltd. | Sustained-release nucleic acid matrix compositions |
| CN104508101A (zh) * | 2011-12-28 | 2015-04-08 | 艾勒旺斯可再生科学公司 | 可再生脂肪酸蜡及其制造方法 |
-
2010
- 2010-07-14 CN CN201080034537.XA patent/CN102470105B/zh active Active
- 2010-07-14 US US13/383,893 patent/US8992979B2/en active Active
- 2010-07-14 EP EP10799520.1A patent/EP2453877B1/en active Active
- 2010-07-14 CA CA2767973A patent/CA2767973C/en active Active
- 2010-07-14 IN IN570DEN2012 patent/IN2012DN00570A/en unknown
- 2010-07-14 CN CN201510441212.8A patent/CN105126179B/zh active Active
- 2010-07-14 WO PCT/IL2010/000563 patent/WO2011007353A1/en not_active Ceased
- 2010-07-14 JP JP2012520148A patent/JP5738856B2/ja active Active
- 2010-07-14 AU AU2010272167A patent/AU2010272167B2/en active Active
- 2010-07-14 ES ES10799520T patent/ES2732149T3/es active Active
-
2015
- 2015-02-17 US US14/623,528 patent/US10463617B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011528031A5 (enExample) | ||
| JP6053083B2 (ja) | 徐放性薬剤キャリア組成物 | |
| CN102470105B (zh) | 持续释放药物载体组合物 | |
| CN116473946A (zh) | 用于治疗和预防手术部位感染的组合物和方法 | |
| BR102012010542B1 (pt) | Material injetável biorreabsorvível bioativo e processo de preparação de material injetável biorreabsorvível bioativo | |
| JP2014521636A5 (enExample) | ||
| JP2007508039A5 (enExample) | ||
| CN111447944A (zh) | 用于伤口闭合的组合物和方法 | |
| HK1205960B (en) | Sustained-release drug carrier composition | |
| HK1161069B (en) | Sustained-release drug carrier composition | |
| IL210437A (en) | The drug carries a drug for sustained release | |
| EA041251B1 (ru) | Применение фармацевтической композиции для лечения или профилактики инфекций области разреза при хирургическом вмешательстве |